Silence Therapeutics Growth Metrics (2019-2026) | SLN

1Y3Y5Y7Y10YAll
Download Data
Growth Metrics Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
Assets Growth (1y) (Quarter) -35.13%-37.87%
Assets (QoQ) (Quarter) -8.56%-10.83%-11.16%-10.46%-12.42%
Capital Expenditures Growth (1y) (Quarter) -121.18%110.73%
Capital Expenditures (QoQ) (Quarter) -856.47%219.60%-99.48%-550.00%483.33%
Cash & Equivalents Growth (1y) (Quarter) -37.17%108.59%173.50%-35.14%4.30%80.93%-90.71%-48.64%
Cash & Equivalents Growth (3y) (Quarter) 53.04%54.67%22.76%6.97%-44.02%
Cash & Equivalents Growth (5y) (Quarter) 19.38%47.50%-20.82%
Cash & Equivalents (QoQ) (Quarter) 12.50%-69.42%144.85%-88.97%521.62%
Cash from Investing Activities Growth (1y) (Quarter) 11.07%-3,532.56%234.48%-180.66%122.53%
Cash from Investing Activities (QoQ) (Quarter) 99.91%-88,597.67%273.37%-167.12%96.48%3,383.55%-204.00%118.75%
Cash from Operations Growth (1y) (Quarter) -34.63%-302.87%57.50%36.99%-26.76%
Cash from Operations (QoQ) (Quarter) 40.84%-373.41%-7.32%55.21%-77.03%50.05%-59.10%9.89%
EBITDA Margin Growth (1y) (Quarter) -2.00M-0.78M-1.45M-3.66M1.63M
EBITDA Margin (QoQ) (Quarter) -0.29M0.09M0.20M-2.00M0.93M-0.58M-2.01M3.29M
EBIT Growth (1y) (Quarter) -409.03%-2.46%12.51%-186.33%44.61%
EBIT Margin Growth (1y) (Quarter) -2.00M-0.78M-1.45M-3.66M1.63M
EBIT Margin (QoQ) (Quarter) -0.29M0.09M0.20M-2.00M0.93M-0.58M-2.01M3.29M
EBIT (QoQ) (Quarter) -319.06%-28.26%85.49%-552.78%15.65%-9.52%52.52%-26.29%
EBT Growth (1y) (Quarter) -1,279.59%-40.03%40.96%-193.22%47.57%
EBT Margin Growth (1y) (Quarter) -2.01M-0.98M-1.08M-3.47M1.65M
EBT Margin (QoQ) (Quarter) -0.24M0.01M0.24M-2.01M0.79M-0.10M-2.14M3.11M
EBT (QoQ) (Quarter) -844.25%-81.77%135.57%-325.96%4.16%23.36%43.84%-27.08%
Enterprise Value Growth (1y) (Quarter) 37.17%-119.92%-159.40%35.14%-4.30%-177.47%54.26%35.37%
Enterprise Value Growth (3y) (Quarter) -53.04%-54.67%-20.62%-23.36%-9.80%
Enterprise Value Growth (5y) (Quarter) -19.38%-60.67%-17.37%
Enterprise Value (QoQ) (Quarter) -11.87%45.16%-7.19%30.44%-58.05%
EPS (Basic) Growth (1y) (Quarter) -1,048.66%-37.01%41.25%-147.50%47.58%
EPS (Basic) (QoQ) (Quarter) -703.70%-78.66%169.47%-215.16%4.13%23.39%43.84%-27.07%
EPS (Diluted) Growth (1y) (Quarter) -1,048.66%-37.01%41.25%-147.50%47.58%
EPS (Diluted) (QoQ) (Quarter) -703.70%-78.66%169.47%-215.16%4.13%23.39%43.84%-27.07%
FCF Margin Growth (1y) (Quarter) -0.86M-0.90M-0.52M-5.08M0.50M
FCF Margin (QoQ) (Quarter) -0.06M-0.10M0.16M-0.86M-0.10M0.28M-4.40M4.72M
Free Cash Flow Growth (1y) (Quarter) -34.67%-296.31%56.12%38.70%-26.72%
Free Cash Flow (QoQ) (Quarter) 39.91%-354.39%-13.16%56.41%-76.83%49.69%-58.09%9.89%
Gross Margin Growth (1y) (Quarter) -0.00M0.04M0.02M-0.00M0.00M
Gross Margin (QoQ) (Quarter) -0.04M0.02M0.02M-0.00M8.00-231.00496.000.00M
Gross Profit Growth (1y) (Quarter) -99.32%105.39%104.44%-99.91%367.05%
Gross Profit (QoQ) (Quarter) -119.98%16.92%1,186.74%-99.62%57.95%-31.65%-76.84%1,768.18%
Interest Coverage Ratio Growth (1y) (Quarter) -109,860.74%
Net Cash Flow Growth (1y) (Quarter) -176.62%-448.30%172.44%-283.30%90.11%
Net Cash Flow (QoQ) (Quarter) -105.76%-1,209.58%169.11%-247.03%58.80%273.03%-274.86%92.07%
Net Income Growth (1y) (Quarter) -1,134.00%-38.47%41.04%-148.51%47.57%
Net Income (QoQ) (Quarter) -754.46%-79.92%168.26%-217.59%4.12%23.38%43.84%-27.08%
Net Income towards Common Stockholders Growth (1y) (Quarter) -1,134.00%-38.47%41.04%-148.51%47.57%
Net Income towards Common Stockholders (QoQ) (Quarter) -754.46%-79.92%168.26%-217.59%4.12%23.38%43.84%-27.08%
Net Margin Growth (1y) (Quarter) -2.01M-0.97M-1.08M-3.47M1.65M
Net Margin (QoQ) (Quarter) -0.25M0.01M0.25M-2.02M0.79M-0.10M-2.14M3.11M
Operating Income Growth (1y) (Quarter) -409.03%-2.46%12.51%-186.33%44.61%
Operating Income (QoQ) (Quarter) -319.06%-28.26%85.49%-552.78%15.65%-9.52%52.52%-26.29%
Operating Margin Growth (1y) (Quarter) -2.00M-0.78M-1.45M-3.66M1.63M
Operating Margin (QoQ) (Quarter) -0.29M0.09M0.20M-2.00M0.93M-0.58M-2.01M3.29M
Profit After Tax Growth (1y) (Quarter) -1,134.00%-38.47%41.04%-195.92%47.42%
Profit After Tax (QoQ) (Quarter) -754.46%-79.92%134.61%-331.91%4.12%23.38%43.70%-27.12%
Property, Plant & Equipment (Net) Growth (1y) (Quarter) -63.78%-1.19%9.54%167.85%-82.26%-19.21%-13.04%-17.54%
Property, Plant & Equipment (Net) Growth (3y) (Quarter) -26.81%42.59%-19.56%-27.32%-50.05%
Property, Plant & Equipment (Net) Growth (5y) (Quarter) -28.54%-16.11%-18.22%
Property, Plant & Equipment (Net) (QoQ) (Quarter) -6.88%4.84%-6.76%-4.47%-11.70%
Return on Assets Growth (1y) (Quarter) 0.00M
Return on Assets (QoQ) (Quarter) 0.00M0.00M0.00M0.00M
Return on Capital Employed Growth (1y) (Quarter) -0.00M
Return on Capital Employed (QoQ) (Quarter) -472.00-581.00-0.00M308.00
Return on Sales Growth (1y) (Quarter) -201.00-97.00-108.00-347.00165.00
Return on Sales (QoQ) (Quarter) -25.001.0025.00-202.0079.00-10.00-214.00311.00
Revenue Growth (1y) (Quarter) -99.10%-72.00%-89.39%-99.87%197.18%
Revenue (QoQ) (Quarter) -94.90%87.25%1,589.25%-99.44%57.75%-29.02%-78.62%1,141.18%
Share-based Compensation Growth (1y) (Quarter) -14.04%-49.65%-37.67%-102.16%-30.88%
Share-based Compensation (QoQ) (Quarter) 0.56%-1.79%-2.11%-11.08%-41.10%21.58%-103.39%2,945.35%
Tax Rate Growth (1y) (Quarter) 113.0013.00
Tax Rate (QoQ) (Quarter) 0.00M103.00-0.01M3.00